Zhihui Kuang
No. 88, Jiefang Road
Hangzhou, 310009, China
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Integrating perfluorocarbon and type-I photosensitizer into a single molecule: a phenothiazine-based platform for hypoxia-tolerant PDT.
Journal: RSC advances
Published: June 17, 2026
Engineered with tannic acid-magnesium metal-phenolic frameworks: A multifunctional 3D-printed PCL/TCP scaffold for bone regeneration.
Journal: Biomaterials advances
Published: February 16, 2026
Phycocyanin-functionalized selenium nanoparticles attenuate osteoarthritis through ferroptosis suppression and modulation of the MAPK pathway.
Journal: Materials today. Bio
Published: December 29, 2025
IAR025, a novel anti-DLL3 x CD3-bispecific antibody, displays high antitumor efficacy in preclinical models of small-cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: December 24, 2025
Fabrication and Properties of Multi-Functional of Tannic Acid-Modified Sodium Alginate/Chitosan Microspheres for Bone Defect Repair.
Journal: Annals of biomedical engineering
Published: December 18, 2024
Pulchinenoside C Attenuates the Development of Osteoarthritis by Inhibiting the PI3K/AKT/NF-κB Signalling Pathway.
Journal: Journal of cellular and molecular medicine
Published: April 09, 2024
Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
Journal: International immunopharmacology
Published: November 21, 2022
A comprehensive pan-cancer analysis unveiling the oncogenic effect of plant homeodomain finger protein 14 (PHF14) in human tumors.
Journal: Frontiers in genetics
Published: October 18, 2022
Facile synthesis of curcumin-containing poly(amidoamine) dendrimers as pH-responsive delivery system for osteoporosis treatment.
Journal: Colloids and surfaces. B, Biointerfaces
Published: September 07, 2022
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies.
Journal: Cancer immunology, immunotherapy : CII
Published: March 18, 2022
Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity.
Journal: Cell reports. Medicine
Published: December 08, 2021
Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance.
Journal: The Journal of clinical investigation
Published: September 13, 2021
Last Updated: 09/26/2026